Erenumab shows sustained efficacy and safety in difficult-to-treat episodic migraineJanuary 10, 2022Headache & Migraine
Erenumab beats topiramate for migraine in first head-to-head trialNovember 18, 2021Headache & Migraine
Largest ever review of new daily persistent headache assesses its clinical featuresNovember 18, 2021Headache & Migraine
Pandemic survey: Forty-six percent of pediatric headache patients got worseOctober 14, 2021Headache & Migraine
Assessing headache severity via migraine symptoms can help predict outcomesSeptember 16, 2021Headache & Migraine
